A randomised study with subcutaneous low-dose interleukin 2 alone vs interleukin 2 plus the pineal neurohormone melatonin in advanced solid neoplasms other than renal cancer and melanoma (Q35978082)

From Wikidata

Jump to navigation Jump to search

scientific article

edit

Language	Label	Description	Also known as
English	A randomised study with subcutaneous low-dose interleukin 2 alone vs interleukin 2 plus the pineal neurohormone melatonin in advanced solid neoplasms other than renal cancer and melanoma	scientific article

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PMC publication ID

1968792

retrieved

11 August 2017

title

A randomised study with subcutaneous low-dose interleukin 2 alone vs interleukin 2 plus the pineal neurohormone melatonin in advanced solid neoplasms other than renal cancer and melanoma (English)

1 reference

stated in

Europe PubMed Central

PMC publication ID

1968792

retrieved

11 August 2017

author name string

Lissoni P

series ordinal

1

1 reference

stated in

Europe PubMed Central

PMC publication ID

1968792

retrieved

11 August 2017

Barni S

series ordinal

2

1 reference

stated in

Europe PubMed Central

PMC publication ID

1968792

retrieved

11 August 2017

Tancini G

series ordinal

3

1 reference

stated in

Europe PubMed Central

PMC publication ID

1968792

retrieved

11 August 2017

Ardizzoia A

series ordinal

4

1 reference

stated in

Europe PubMed Central

PMC publication ID

1968792

retrieved

11 August 2017

Ricci G

series ordinal

5

1 reference

stated in

Europe PubMed Central

PMC publication ID

1968792

retrieved

11 August 2017

Aldeghi R

series ordinal

6

1 reference

stated in

Europe PubMed Central

PMC publication ID

1968792

retrieved

11 August 2017

Brivio F

series ordinal

7

1 reference

stated in

Europe PubMed Central

PMC publication ID

1968792

retrieved

11 August 2017

Tisi E

series ordinal

8

1 reference

stated in

Europe PubMed Central

PMC publication ID

1968792

retrieved

11 August 2017

Rovelli F

series ordinal

9

1 reference

stated in

Europe PubMed Central

PMC publication ID

1968792

retrieved

11 August 2017

Rescaldani R

series ordinal

10

1 reference

stated in

Europe PubMed Central

PMC publication ID

1968792

retrieved

11 August 2017

language of work or name

English

0 references

publication date

1 January 1994

1 reference

stated in

Europe PubMed Central

PMC publication ID

1968792

retrieved

11 August 2017

published in

British Journal of Cancer

1 reference

stated in

Europe PubMed Central

PMC publication ID

1968792

retrieved

11 August 2017

volume

69

1 reference

stated in

Europe PubMed Central

PMC publication ID

1968792

retrieved

11 August 2017

issue

1

1 reference

stated in

Europe PubMed Central

PMC publication ID

1968792

retrieved

11 August 2017

page(s)

196-199

1 reference

stated in

Europe PubMed Central

PMC publication ID

1968792

retrieved

11 August 2017

cites work

Lymphokine-activated killer cell phenomenon. Lysis of natural killer-resistant fresh solid tumor cells by interleukin 2-activated autologous human peripheral blood lymphocytes

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1968792

retrieved

2 October 2017

Cancer, cytokines, and cytotoxic cells: interleukin-2 in the immunotherapy of human neoplasms

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1968792

retrieved

2 October 2017

The clinical effects of prolonged treatment of patients with advanced cancer with low-dose subcutaneous interleukin-2 [corrected]

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1968792

retrieved

2 October 2017

Suppressor Cells in Neoplastic Disease

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1968792

retrieved

2 October 2017

Circadian variation of lymphocyte subpopulations: a study with monoclonal antibodies.

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1968792

retrieved

11 July 2018

Role of the pineal gland in immunity. Circadian synthesis and release of melatonin modulates the antibody response and antagonizes the immunosuppressive effect of corticosterone

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1968792

retrieved

11 July 2018

The neuroendocrine effects of interleukin-2 treatment

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1968792

retrieved

11 July 2018

Endocrine effects of a 24-hour intravenous infusion of interleukin-2 in the immunotherapy of cancer

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1968792

retrieved

11 July 2018

Continuous interleukin-2 and lymphokine-activated killer cells for advanced cancer: a National Biotherapy Study Group trial

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1968792

retrieved

11 July 2018

Immunological effects of a single evening subcutaneous injection of low-dose interleukin-2 in association with the pineal hormone melatonin in advanced cancer patients

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1968792

retrieved

11 July 2018

Increase in soluble interleukin-2 receptor and neopterin serum levels during immunotherapy of cancer with interleukin-2

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1968792

retrieved

24 September 2018

Continuous infusion recombinant interleukin-2 (rIL-2) in adoptive cellular therapy of renal carcinoma and other malignancies

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/8286206

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Neuroimmunotherapy of advanced solid neoplasms with single evening subcutaneous injection of low-dose interleukin-2 and melatonin: preliminary results

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/8286206

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

DOI

10.1038/BJC.1994.34

1 reference

stated in

Europe PubMed Central

PMC publication ID

1968792

retrieved

11 August 2017

PMC publication ID

1968792

1 reference

stated in

Europe PubMed Central

PMC publication ID

1968792

retrieved

11 August 2017

PubMed publication ID

8286206

1 reference

stated in

Europe PubMed Central

PMC publication ID

1968792

retrieved

11 August 2017

ResearchGate publication ID

14913500

0 references

 

Sitelinks

Wikipedia(0 entries)

edit

Wikibooks(0 entries)

edit

Wikinews(0 entries)

edit

Wikiquote(0 entries)

edit

Wikisource(0 entries)

edit

Wikiversity(0 entries)

edit

Wikivoyage(0 entries)

edit

Wiktionary(0 entries)

edit

Multilingual sites(0 entries)

edit

Retrieved from "https://www.wikidata.org/w/index.php?title=Q35978082&oldid=2198017837"